{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:48:09Z","timestamp":1791460089866,"version":"4.3.4"},"reference-count":65,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":3220,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The association between Hashimoto thyroiditis (HT) and papillary thyroid carcinoma (PTC) has been originally suggested by retrospective pathological studies and has recently been re-evaluated and proposed on the basis of several fine-needle aspiration cytology (FNAC) studies. In FNAC studies, the association between HT and PTC is based on the comparison of anti-thyroid autoantibodies (ATA) (anti-thyroperoxidase [TPOAb] and anti-thyroglobulin [TgAb]), thyroid function (TSH), and cytology with histology of thyroid nodules and lymphocytic thyroid infiltration (LTI) of operated thyroid glands. Most of the pathological studies found a high prevalence rate of PTC in HT. In most FNAC studies, the risk ratio of PTC in HT patients was evaluated using multivariate statistical analysis: increased TSH levels represented the main and common independent risk factor of malignancy, although it resulted not consistently related to HT. On the other hand, several studies provided a positive relationship between ATA and PTC, particularly with TgAb. Two recent FNAC studies from the same referral center clearly demonstrated an independent risk for thyroid malignancy conferred by both TPOAb and TgAb, confirming the role of increased TSH levels, and found a significant association between PTC and ATA and diffuse LTI at histology. These studies are consistent with the hypothesis that autoimmune thyroid inflammation and increased serum TSH concentration may be involved in thyroid tumor growth. The complex relationship between HT and PTC, which involves immunological\/hormonal pathogenic links, needs to be further investigated with prospective studies.<\/jats:p>","DOI":"10.1159\/000468928","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T17:07:23Z","timestamp":1493226443000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":68,"title":["Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies"],"prefix":"10.1530","volume":"6","author":[{"given":"Francesco","family":"Boi","sequence":"first","affiliation":[{"name":"1Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Pani","sequence":"additional","affiliation":[{"name":"1Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mariotti","sequence":"additional","affiliation":[{"name":"1Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"2026070712492890700_ref1","doi-asserted-by":"crossref","unstructured":"Weetman AP: Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003;148: 1\u20139.10.1530\/eje.0.148000112534350","DOI":"10.1530\/eje.0.1480001"},{"key":"2026070712492890700_ref2","doi-asserted-by":"crossref","unstructured":"Tomer Y: Genetic dissection of familial autoimmune thyroid diseases using whole genome screening. Autoimmun Rev 2002;1: 198\u2013204.10.1016\/S1568-9972(02)00053-812848996","DOI":"10.1016\/S1568-9972(02)00053-8"},{"key":"2026070712492890700_ref3","doi-asserted-by":"crossref","unstructured":"Prummel MF, Strieder T, Wiersinga WM: The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004;150: 605\u2013618.10.1530\/eje.0.150060515132715","DOI":"10.1530\/eje.0.1500605"},{"key":"2026070712492890700_ref4","doi-asserted-by":"crossref","unstructured":"Dailey ME, Lindsay S, Skahen R: Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955;70: 291\u2013297.13227748","DOI":"10.1001\/archsurg.1955.01270080137023"},{"key":"2026070712492890700_ref5","unstructured":"Hirabayashi RN, Lindsay S: The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 1965;121: 243\u2013252.14320370"},{"key":"2026070712492890700_ref6","unstructured":"Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E: The incidence of thyroid carcinoma in patients with Hashimoto\u2019s thyroiditis and solitary cold nodules. Surgery 1985;98: 1202\u20131206.3840923"},{"key":"2026070712492890700_ref7","unstructured":"Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E: The incidence of thyroid carcinoma in Hashimoto\u2019s thyroiditis. Am Surg 1987;53: 442\u2013445.3605864"},{"key":"2026070712492890700_ref8","doi-asserted-by":"crossref","unstructured":"Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995;76: 2312\u20132318.10.1002\/1097-0142(19951201)76:11&lt;2312::AID-CNCR2820761120&gt;3.0.CO;2-H8635037","DOI":"10.1002\/1097-0142(19951201)76:11<2312::AID-CNCR2820761120>3.0.CO;2-H"},{"key":"2026070712492890700_ref9","doi-asserted-by":"crossref","unstructured":"Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP: Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 1999;126: 1070\u20131076.10.1067\/msy.2099.10143110598190","DOI":"10.1067\/msy.2099.101431"},{"key":"2026070712492890700_ref10","doi-asserted-by":"crossref","unstructured":"Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S: High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 2005;153: 637\u2013642.10.1530\/eje.1.0202016260421","DOI":"10.1530\/eje.1.02020"},{"key":"2026070712492890700_ref11","unstructured":"Boi F, Minerba L, Lai ML, Marziani B, Figus B, Spanu F, Borghero A, Mariotti S: Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules. J Endocrinol Invest 2013;36: 313\u2013320.10.3275\/857922931861"},{"key":"2026070712492890700_ref12","doi-asserted-by":"crossref","unstructured":"Guarino V, Castellone MD, Avilla E, Melillo RM: Thyroid cancer and inflammation. Mol Cell Endocrinol 2010;321: 94\u2013102.10.1016\/j.mce.2009.10.00319835928","DOI":"10.1016\/j.mce.2009.10.003"},{"key":"2026070712492890700_ref13","doi-asserted-by":"crossref","unstructured":"Vella V, Mineo R, Frasca F, Mazzon E, Pandini G, Vigneri R, Belfiore A: Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves\u2019 disease. J Clin Endocrinol Metab 2004;89: 2880\u20132889.10.1210\/jc.2003-03163915181072","DOI":"10.1210\/jc.2003-031639"},{"key":"2026070712492890700_ref14","doi-asserted-by":"crossref","unstructured":"Coussens LM, Werb Z: Inflammation and cancer. Nature 2002;6917: 860\u2013867.10.1038\/nature0132212490959","DOI":"10.1038\/nature01322"},{"key":"2026070712492890700_ref15","doi-asserted-by":"crossref","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30: 1073\u20131081.10.1093\/carcin\/bgp12719468060","DOI":"10.1093\/carcin\/bgp127"},{"key":"2026070712492890700_ref16","doi-asserted-by":"crossref","unstructured":"Okayasu I: The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma. Endocr Pathol 1997;8: 225\u2013230.10.1007\/BF0273878912114726","DOI":"10.1007\/BF02738789"},{"key":"2026070712492890700_ref17","doi-asserted-by":"crossref","unstructured":"Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H: The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995;80: 3421\u20133424.10.1210\/jc.80.12.34218530576","DOI":"10.1210\/jcem.80.12.8530576"},{"key":"2026070712492890700_ref18","doi-asserted-by":"crossref","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohou\u00e9 F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pag\u00e8s F: Type, density, and location of immune cells within colorectal tumors predict clinical outcome. Science 2006; 313: 1960\u20131964.10.1126\/science.112913917008531","DOI":"10.1126\/science.1129139"},{"key":"2026070712492890700_ref19","doi-asserted-by":"crossref","unstructured":"Okayasu I: The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma. Endocr Pathol 1997;8: 225\u2013230.10.1007\/BF0273878912114726","DOI":"10.1007\/BF02738789"},{"key":"2026070712492890700_ref20","doi-asserted-by":"crossref","unstructured":"Kim KW, Park YJ, Kim EH, Park SY, Park do J, Ahn SH, Park do J, Jang HC, Cho BY: Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto\u2019s thyroiditis. Head Neck 2011;33: 691\u2013695.10.1002\/hed.2151821484918","DOI":"10.1002\/hed.21518"},{"key":"2026070712492890700_ref21","doi-asserted-by":"crossref","unstructured":"Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM: Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k\/Ak pathway. J Am Coll Surg 2007;204: 764\u2013773.10.1016\/j.jamcollsurg.2006.12.03717481480","DOI":"10.1016\/j.jamcollsurg.2006.12.037"},{"key":"2026070712492890700_ref22","doi-asserted-by":"crossref","unstructured":"Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P: Hashimoto\u2019s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 2011;18: 429\u2013437.10.1530\/ERC-11-002821565972","DOI":"10.1530\/ERC-11-0028"},{"key":"2026070712492890700_ref23","doi-asserted-by":"crossref","unstructured":"Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6: 345\u201352.10.1038\/ni117815785760","DOI":"10.1038\/ni1178"},{"key":"2026070712492890700_ref24","doi-asserted-by":"crossref","unstructured":"Kashima K, Yokoyama S, Noguchi S, et al: Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998;8: 197\u2013202.10.1089\/thy.1998.8.1979545105","DOI":"10.1089\/thy.1998.8.197"},{"key":"2026070712492890700_ref25","doi-asserted-by":"crossref","unstructured":"Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP: Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999;84: 458\u2013463.10.1210\/jcem.84.2.544310022401","DOI":"10.1210\/jcem.84.2.5443"},{"key":"2026070712492890700_ref26","doi-asserted-by":"crossref","unstructured":"Iliadou PK, Effraimidis G, Konstantinos M, Grigorios P, Mitsakis P, Patakiouta F, Pazaitou-Panayiotou K: Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents. Eur J Endocrinol 2015;173: 827\u2013833.10.1530\/EJE-14-104626369577","DOI":"10.1530\/EJE-14-1046"},{"key":"2026070712492890700_ref27","doi-asserted-by":"crossref","unstructured":"Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA: Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013;98: 2409\u20132414.10.1210\/jc.2013-130923609834","DOI":"10.1210\/jc.2013-1309"},{"key":"2026070712492890700_ref28","doi-asserted-by":"crossref","unstructured":"Modi J, Patel A, Terrell R, Tuttle RM, Francis GL: Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes. J Clin Endocrinol Metab 2003;88: 4418\u20134425.10.1210\/jc.2003-03034212970319","DOI":"10.1210\/jc.2003-030342"},{"key":"2026070712492890700_ref29","doi-asserted-by":"crossref","unstructured":"Nikiforova MN, Caudill CM, Biddinger P, Nikiforov YE: Prevalence of RET\/PTC rearrangements in Hashimoto\u2019s thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 2002;10: 15\u201322.11927965","DOI":"10.1177\/106689690201000104"},{"key":"2026070712492890700_ref30","doi-asserted-by":"crossref","unstructured":"Muzza M, Degl\u2019Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L: The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 2010;72: 702\u2013708.10.1111\/j.1365-2265.2009.03699.x20447069","DOI":"10.1111\/j.1365-2265.2009.03699.x"},{"key":"2026070712492890700_ref31","doi-asserted-by":"crossref","unstructured":"Santoro M, Carlomagno F, Melillo RM, Fusco A: Dysfunction of the RET receptor in human cancer. Cell Mol Life Sci 2004;61: 2954\u20132964.10.1007\/s00018-004-4276-815583857","DOI":"10.1007\/s00018-004-4276-8"},{"key":"2026070712492890700_ref32","doi-asserted-by":"crossref","unstructured":"Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M: The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 2005;115: 1068\u20131081.10.1172\/JCI2275815761501","DOI":"10.1172\/JCI200522758"},{"key":"2026070712492890700_ref33","doi-asserted-by":"crossref","unstructured":"Russell JP, Shinohara S, Melillo RM, Castellone MD, Santoro M, Rothstein JL: Tyrosine kinase oncoprotein, RET\/PTC3, induces the secretion of myeloid growth and chemotactic factors. Oncogene 2003;22: 4569\u20134577.10.1038\/sj.onc.120675912881713","DOI":"10.1038\/sj.onc.1206759"},{"key":"2026070712492890700_ref34","doi-asserted-by":"crossref","unstructured":"Waugh DJ, Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14: 6735\u20136741.10.1158\/1078-0432.CCR-07-484318980965","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"key":"2026070712492890700_ref35","doi-asserted-by":"crossref","unstructured":"Russell JP, Engiles JB, Rothstein JL: Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 2004;172: 4059\u20134067.10.4049\/jimmunol.172.7.405915034017","DOI":"10.4049\/jimmunol.172.7.4059"},{"key":"2026070712492890700_ref36","doi-asserted-by":"crossref","unstructured":"Shinohara S, Rothstein JL: Interleukin 24 is induced by the RET\/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells. Oncogene 2004;23: 7571\u20137579.10.1038\/sj.onc.120796415326486","DOI":"10.1038\/sj.onc.1207964"},{"key":"2026070712492890700_ref37","doi-asserted-by":"crossref","unstructured":"Puxeddu E, Mitsutake N, Knauf JA, Moretti S, Kim HW, Seta KA, Brockman D, Myatt L, Millhorn DE, Fagin JA: Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET\/PTC in thyroid PCCL3 cells through the activation of the MEK ERK pathway. J Biol Chem 2003;278: 52131\u201352138.10.1074\/jbc.M30600320014555660","DOI":"10.1074\/jbc.M306003200"},{"key":"2026070712492890700_ref38","doi-asserted-by":"crossref","unstructured":"Puxeddu E, Knauf JA, Sartor MA, Mitsutake N, Smith EP, Medvedovic M, Tomlinson CR, Moretti S, Fagin JA: RET\/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr Relat Cancer 2005;12: 319\u2013334.10.1677\/erc.1.0094715947106","DOI":"10.1677\/erc.1.00947"},{"key":"2026070712492890700_ref39","doi-asserted-by":"crossref","unstructured":"Xing M: BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005;12: 245\u2013262.10.1677\/erc.1.097815947100","DOI":"10.1677\/erc.1.0978"},{"key":"2026070712492890700_ref40","doi-asserted-by":"crossref","unstructured":"Kim KH, Suh KS, Kang DW, Kang DY: Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto\u2019s thyroiditis. Pathol Int 2005;55: 540\u2013545.10.1111\/j.1440-1827.2005.01866.x16143028","DOI":"10.1111\/j.1440-1827.2005.01866.x"},{"key":"2026070712492890700_ref41","doi-asserted-by":"crossref","unstructured":"Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL: BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 2006;17: 235\u2013241.10.1385\/EP:17:3:23517308360","DOI":"10.1385\/EP:17:3:235"},{"key":"2026070712492890700_ref42","doi-asserted-by":"crossref","unstructured":"Borrello MG, Alberti L, Fischer A, Degl\u2019innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L, Mantovani A, Pierotti MA: Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene. Proc Natl Acad Sci 2005;102: 14825\u201314830.10.1073\/pnas.050303910216203990","DOI":"10.1073\/pnas.0503039102"},{"key":"2026070712492890700_ref43","doi-asserted-by":"crossref","unstructured":"Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P: Role of chemokines in endocrine autoimmune diseases. Endocr Rev 2007;28: 492\u2013520.10.1210\/er.2006-004417475924","DOI":"10.1210\/er.2006-0044"},{"key":"2026070712492890700_ref44","doi-asserted-by":"crossref","unstructured":"Antonelli A, Rotondi M, Fallahi P, Grosso M, Boni G, Ferrari SM, Romagnani P, Serio M, Mariani G, Ferrannini E: Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves\u2019 disease or toxic nodular goiter. J Clin Endocrinol Metab 2007;92: 1485\u20131490.10.1210\/jc.2006-157117244787","DOI":"10.1210\/jc.2006-1571"},{"key":"2026070712492890700_ref45","unstructured":"B\u00fcy\u00fcka\u015f\u0131k O, Hasdemir AO, Yal\u00e7\u0131n E, Celep B, Seng\u00fcl S, Yandak\u00e7\u0131 K, Tun\u00e7 G, K\u00fc\u00e7\u00fckp\u0131nar T, Alkoy S, C\u00f6l C: The association between thyroid malignancy and chronic lymphocytic thyroiditis: should it alter the surgical approach? Endokrynol Pol 2011;62: 303\u2013308.21879469"},{"key":"2026070712492890700_ref46","doi-asserted-by":"crossref","unstructured":"Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS: The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 2012;269: 1013\u20131017.10.1007\/s00405-011-1732-621822854","DOI":"10.1007\/s00405-011-1732-6"},{"key":"2026070712492890700_ref47","doi-asserted-by":"crossref","unstructured":"Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA: Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005;71: 874\u2013878.16468540","DOI":"10.1177\/000313480507101018"},{"key":"2026070712492890700_ref48","doi-asserted-by":"crossref","unstructured":"Bradly DP, Reddy V, Prinz RA, Gattuso P: Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009;146: 1099\u20131104.10.1016\/j.surg.2009.09.02519958937","DOI":"10.1016\/j.surg.2009.09.025"},{"key":"2026070712492890700_ref49","doi-asserted-by":"crossref","unstructured":"Siriweera EH, Ratnatunga NV: Profile of Hashimoto\u2019s thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto\u2019s thyroiditis? J Thyroid Res 2010;2010: 124264.10.4061\/2010\/12426421048834","DOI":"10.4061\/2010\/124264"},{"key":"2026070712492890700_ref50","doi-asserted-by":"crossref","unstructured":"Jankovic B, Le KT, Hershman JM: Clinical Review: Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 2013;98: 474\u2013482.10.1210\/jc.2012-297823293329","DOI":"10.1210\/jc.2012-2978"},{"key":"2026070712492890700_ref51","doi-asserted-by":"crossref","unstructured":"Lee JH, Kim Y, Choi JW, Kim YS: The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol 2013;168: 343\u2013349.10.1530\/EJE-12-090323211578","DOI":"10.1530\/EJE-12-0903"},{"key":"2026070712492890700_ref52","doi-asserted-by":"crossref","unstructured":"Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA: Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91: 4295\u20134301.10.1210\/jc.2006-052716868053","DOI":"10.1210\/jc.2006-0527"},{"key":"2026070712492890700_ref53","doi-asserted-by":"crossref","unstructured":"Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti P, Grasso L, Elisei R, Pinchera A, Vitti P: Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009;16: 1251\u20131260.10.1677\/ERC-09-003619528244","DOI":"10.1677\/ERC-09-0036"},{"key":"2026070712492890700_ref54","doi-asserted-by":"crossref","unstructured":"Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, Malchoff CD: Association of Hashimoto\u2019s thyroiditis with thyroid cancer. Endocr Relat Cancer 2014;21: 845\u2013852.10.1530\/ERC-14-025825217233","DOI":"10.1530\/ERC-14-0258"},{"key":"2026070712492890700_ref55","doi-asserted-by":"crossref","unstructured":"Castagna MG, Belardini V, Memmo S, Maino F, Di Santo A, Toti P, Carli AF, Caruso, G, Pacini F: Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series, but not in cytological series: evidence for selection bias. J Clin Endocrinol Metab 2014;99: 3193\u20133198.10.1210\/jc.2014-130224892990","DOI":"10.1210\/jc.2014-1302"},{"key":"2026070712492890700_ref56","unstructured":"Matesa-Ani\u0107 D, Matesa N, Dabeli\u0107 N, Kusi\u0107 Z: Coexistence of papillary carcinoma and Hashimoto\u2019s thyroiditis. Acta Clin Croat 2009;48: 9\u201312.19623865"},{"key":"2026070712492890700_ref57","doi-asserted-by":"crossref","unstructured":"Anil C, Goksel S, Gursoy A: Hashimoto\u2019s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 2010;20: 601\u2013606.10.1089\/thy.2009.045020470208","DOI":"10.1089\/thy.2009.0450"},{"key":"2026070712492890700_ref58","doi-asserted-by":"crossref","unstructured":"Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Miccoli P, Grasso L, Pinchera A, Vitti P: L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010;17: 231\u2013239.10.1677\/ERC-09-025120167722","DOI":"10.1677\/ERC-09-0251"},{"key":"2026070712492890700_ref59","doi-asserted-by":"crossref","unstructured":"Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY: Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 2010;20: 885\u2013891.10.1089\/thy.2009.038420465529","DOI":"10.1089\/thy.2009.0384"},{"key":"2026070712492890700_ref60","doi-asserted-by":"crossref","unstructured":"Allavena P, Sica A, Solinas G, Porta C, Mantovani A: The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008;66: 1\u20139.10.1016\/j.critrevonc.2007.07.00417913510","DOI":"10.1016\/j.critrevonc.2007.07.004"},{"key":"2026070712492890700_ref61","doi-asserted-by":"crossref","unstructured":"Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS: High prevalence of RET, RAS, and ERK expression in Hashimoto\u2019s thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 2007;17: 1031\u20131038.10.1089\/thy.2007.003517900235","DOI":"10.1089\/thy.2007.0035"},{"key":"2026070712492890700_ref62","doi-asserted-by":"crossref","unstructured":"Boelaert K: The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer 2009;16: 1065\u20131072.10.1677\/ERC-09-015019620248","DOI":"10.1677\/ERC-09-0150"},{"key":"2026070712492890700_ref63","doi-asserted-by":"crossref","unstructured":"Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C: Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81: 4318\u20134823.10.1210\/jc.81.12.43188954034","DOI":"10.1210\/jcem.81.12.8954034"},{"key":"2026070712492890700_ref64","doi-asserted-by":"crossref","unstructured":"Consorti F, Loponte M, Milazzo F, Potasso L, Antonaci A: Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto\u2019s thyroiditis. Eur Surg Res 2010;45: 333\u2013337.10.1159\/0003209542105189","DOI":"10.1159\/000320954"},{"key":"2026070712492890700_ref65","doi-asserted-by":"crossref","unstructured":"Chen YK, Lin CL, Cheng FT, Sung FC, Kao CH: Cancer risk in patients with Hashimoto\u2019s thyroiditis: a nationwide cohort study. Br J Cancer 2013; 29: 2496\u20132501.10.1038\/bjc.2013.59724084773","DOI":"10.1038\/bjc.2013.597"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/468928","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/6\/4\/178\/29923\/etj468928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/6\/4\/178\/29923\/etj468928.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:18:04Z","timestamp":1783444684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/6\/4\/178\/4050\/Thyroid-Autoimmunity-and-Thyroid-Cancer-Review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000468928","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,24]]}}}